Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

Spending on digital pathology equipment is rising as a result of the sheer rise in cancer cases. When it comes to blood cancer and lung cancer in particular, complications from late cancer diagnosis entail the utilisation of considerable capital resources during treatment and diagnosis.


NEWARK, Del: By 2022, the global Digital Pathology Market is anticipated to reach US$6,199 Mn, according to Future Market Insights. The market for digital pathology goods and services will increase at a CAGR of 13.5% during the projected period, reaching US$ 22,870.2 Mn by 2032.

Due to technological developments and the broad adoption of electronic medical records in the healthcare sector, digital pathology solutions are becoming more and more common. Cloud-based information systems are expected to expand at a CAGR of 16.9% through 2032, while on-premise systems will continue to dominate with US$ 626.8 Mn.

The rising use of advanced analytics in pharmaceutical and medical testing is one of the major drivers of the market for digital pathology. Analytics are being implemented by healthcare financing companies and governmental organisations through claim management and fraud prevention, which is driving the market’s expansion.

Request a Sample of this Report@

Surge in R&D in Digital Pathology to Augment Sales in Forthcoming Years

The digital pathology market has expanded significantly as a result of the industry’s increased spending in biosimilar research and development projects, particularly for the treatment of cancer and Covid-19.

Pharmaceutical companies are entrusting regulatory consultants, in-vitro diagnostics (IVD) facilities, clinical laboratories, and contract research organisations (CROs) with the task of developing biosimilars. These businesses are growing to provide their clients more affordable solutions, necessitating the usage of digital pathology devices to diagnose, investigate, and create efficient healthcare solutions.

Cancer diagnostic Opens New Avenues for Digital Pathology Companies

Spending on digital pathology equipment is rising as a result of the sheer rise in cancer cases. When it comes to blood cancer and lung cancer in particular, complications from late cancer diagnosis entail the utilisation of considerable capital resources during treatment and diagnosis. The demand for these systems in the cancer research sector is being driven by the success of digital pathology in research. Government investors are being encouraged to invest in digital pathology systems for clinical diagnostics as a result of this. Cancer diagnosis and therapy monitoring involve large financial outlays. This explains why there is a huge need for digital pathology solutions.

Ask An Analyst@

Competitive Landscape

  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Huron Technologies International Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • Hamamatsu Photonics K.K.
  • Carl Zeiss AG
  • Nikon Corporation
  • 3DHISTECH Ltd.
  • Hologic Inc.
  • PerkinElmer, Inc.
  • Visiopharm
  • OptraSCAN, Inc.
  • Inspirata, Inc.
  • Sectra AB

Some of the recent developments in digital pathology market are as follows:

  • In May 2021, Leica Biosystems joined the European Society for Digital and Integrative Pathology (ESDIP) to assist pathology labs in developing laboratories in accordance with modern digital pathology instruments.
  • In March 2021, Roche inked a comprehensive merger agreement with GenMark Diagnostics to broaden its product and distribution channel for European consumers.

Request Customization@

Key Segments Profiled in the Global Digital Pathology Market

Digital Pathology by Product Type:

  • Digital Pathology Equipment
    • Whole Slide Scanners
      • Brightfield Slide Scanners
      • Fluorescence Slide Scanners
      • Combination Slide Scanners
    • Clinical Microscope
    • Tissue Microarrays
  • Digital Pathology Software
    • Image Viewing and Analysis Software
      • On-premise
      • Cloud-based
  • Digital Pathology Information Systems
    • On-premise
    • Cloud-based
  • Digital Pathology Services
    • Installation and Integration Services
    • Consulting Services
    • Maintenance and Validation Services

Browse full Report@

Digital Pathology by Application:

  • Clinical Pathology
  • Molecular Diagnostics
  • Basic & Applied Research
  • Drug Development
  • Others

Digital Pathology by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Forensic Laboratories
  • Research Institutes
  • Contract Research Organizations (CROs)
  • Clinics

Use promo code ->> FMITODAY to get a flat 20% discount

Table of Content

  1. Executive Summary

1.1. Global Market Outlook

1.2. Global Market Outlook

1.3. Demand Side Trends

1.4. Supply Side Trends

1.5. Analysis and Recommendations

  1. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

  1. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

Request a Complete TOC of this Report with figures@

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain

Mortuary Bag Market Size: The global mortuary bag market is expected to grow at 4.8% CAGR to reach a market valuation of US$ 656.61 Million by the end of 2033, up from US$ 392.62 Million that was recorded for 2022.

Medical Rehabilitation Robotics Market Share: The global medical rehabilitation robotics market is forecasted to expand at 15.2% CAGR to reach a market valuation of US$ 1.76 Billion by the end of 2033, up from US$ 366.2 Million that was recorded for 2022.

Histiocytosis Treatment Market Demand: As per Future Market Insights, the histiocytosis treatment market is anticipated to attain a value pool of US$ 40 billion by 2023-end. Global demand for histiocytosis treatment is expected to rise at a CAGR of 9% to US$ 95 billion in 2033.

Choroideremia Treatment Market Growth: The market is expected to attain a value pool of US$ 3.5 billion by the end of 2023, marking a substantial growth in demand. As we move forward, this trend is only set to continue, with global demand for Choroideremia Treatment projected to rise at a modest CAGR of 5.5% to reach an impressive US$ 6 billion by 2033.

Companion Animal Drugs Market Opportunity: The global companion animal drugs market is forecasted to expand at 4.4% CAGR to reach a market valuation of US$ 59.2 Billion by the end of 2033, up from US$ 36.7 Billion that was recorded for 2022.

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

LinkedIn| TwitterBlogs | YouTube

For Sales Enquiries:

Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts